Mirae Asset Global ETFs Holdings’s Amicus Therapeutics FOLD Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.34M	Sell	161,842 -5,401	-3%	-$77.4K	﹤0.01%	1107
2025 Q4	$2.38M	Buy	167,243 +18,516	+12%	+$182K	﹤0.01%	1073
2025 Q3	$1.17M	Sell	148,727 -116,287	-44%	-$828K	﹤0.01%	1395
2025 Q2	$1.52M	Buy	265,014 +18,002	+7%	+$116K	﹤0.01%	1235
2025 Q1	$2.02M	Sell	247,012 -11,137	-4%	-$103K	﹤0.01%	1136
2024 Q4	$2.43M	Buy	258,149 +24,316	+10%	+$253K	0.01%	1030
2024 Q3	$2.5M	Sell	233,833 -1,749	-0.7%	-$19K	0.01%	1016
2024 Q2	$2.34M	Buy	+235,582	New	+$2.42M	0.01%	1007

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's FOLD Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Amicus Therapeutics (FOLD) stake by 3.2% in Q1 2026, selling an estimated $77.4K and leaving 161,842 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1107.

Mirae Asset Global ETFs Holdings first reported a position in FOLD in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.5M in Q3 2024. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

Mirae Asset Global ETFs Holdings held 161,842 shares of Amicus Therapeutics worth $2.34M as of Q1 2026.
Mirae Asset Global ETFs Holdings sold 5,401 Amicus Therapeutics shares in Q1 2026, an estimated $77.4K.
Amicus Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1107 holding.
Mirae Asset Global ETFs Holdings first reported a position in Amicus Therapeutics in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Amicus Therapeutics position peaked at $2.5M in Q3 2024.
298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.